Advertisement
Medtronic
Subscribe to Medtronic
View Sample

FREE Email Newsletter

Study: Promising Results with Novel Approach to Medtronic Cardiac Resynchronization Therapy

May 9, 2014 2:02 pm | by Medtronic | News | Comments

Medtronic, Inc. today released study findings that show heart failure patients who have limited options for implanted device therapy may benefit from a novel implant technique for cardiac resynchronization therapy (CRT) devices. Data from...

Medtronic Agrees to Settle Certain INFUSE Bone Graft Product Liability Cases

May 6, 2014 11:11 am | by Medtronic | News | Comments

Medtronic Inc. has announced that it has agreed with certain plaintiffs' counsel to settle their inventories of filed and unfiled product liability claims related to INFUSE Bone Graft. Under the terms of the agreement, Medtronic has agreed...

MHIF Given the Chance at Its First Implant of World’s Smallest Cardiac Pacemaker

May 5, 2014 2:03 pm | by The Minneapolis Heart Institute Foundation (MHIF) | News | Comments

The Minneapolis Heart Institute Foundation (MHIF) today announced its first implant of the world’s smallest pacemaker: the Medtronic Micra Transcatheter Pacing System (TPS) in the Midwest. The device was implanted by Dr. Charles Gornick...

Advertisement

World's Smallest, Leadless Heart Pacemaker Implanted at Ohio State

May 2, 2014 12:37 pm | by Ohio State University Wexner Medical Center | News | Comments

It’s about the size of a large vitamin pill and, for the first time in Ohio, the smallest heart pacemaker available is being tested at The Ohio State University Wexner Medical Center. Doctors at Ohio State’s Richard M. Ross Heart Hospital...

Medtronic’s Viva Cardiac Resynchronization Therapy-Pacemaker Gains CE Mark

May 1, 2014 10:10 am | by Medtronic | News | Comments

Medtronic, Inc. has announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P. The Viva CRT-P is not approved for sale in the United States. The Viva... 

Positive Outcomes for CoreValve Patients Treated via Alternative Access Routes

April 30, 2014 10:19 am | by Medtronic Inc. | News | Comments

Medtronic, Inc. today revealed new data demonstrating positive outcomes for extreme risk patients with severe aortic stenosis who were treated with the CoreValve System via alternative access approaches. The compelling data were unveiled...

Medtronic’s Sutureless Heart Valve First to Show Five-Year Safety and Efficacy Outcomes

April 29, 2014 10:13 am | by Medtronic | News | Comments

Medtronic, Inc. today announced five-year follow-up data demonstrating the safety and performance of the Medtronic 3f Enable Aortic Bioprosthesis - the world's first commercially available sutureless tissue heart valve.  The longest follow...

First U.S. Implant of ICD System that Allows Full-Body MRI Scans

April 22, 2014 10:22 am | by Medtronic | News | Comments

Medtronic has announced the first U.S. implant of the Evera MRI SureScan implantable cardioverter-defibrillator (ICD) System, following U.S. Food and Drug Administration (FDA) approval for its Investigational Device Exemption (IDE) application...

Advertisement

Federal Appeals Court Agrees to Medtronic Request to Postpone Injunction

April 22, 2014 9:18 am | by Medtronic | News | Comments

The Federal Circuit Court of Appeals today granted a request from Medtronic, Inc. to postpone the implementation of an injunction that would have prevented the company from selling its CoreValve System in the United States. This means the...

Endurant AAA Stent Graft Continues Exceptional Long-Term Performance

April 21, 2014 10:18 am | by Medtronic Inc. | News | Comments

The Endurant AAA stent graft system from Medtronic, Inc. continues to demonstrate exceptional long-term performance in the endovascular treatment of abdominal aortic aneurysms, according to new clinical data presented for the first time...

Court Agrees to an Expedited Appeal in CoreValve System

April 21, 2014 9:13 am | by Medtronic Inc. | News | Comments

Medtronic, Inc. today issued an updated statement on the recent ruling by Federal District Court of Delaware. The ruling granted in part Edwards Lifesciences' motion for a preliminary injunction that prevents Medtronic from selling or offering...

Medtronic to Appeal Federal District Court Ruling

April 14, 2014 11:07 am | by Medtronic Inc. | News | Comments

The Federal District Court of Delaware today granted in part Edwards Lifesciences' motion for a preliminary injunction that prevents Medtronic, Inc. from selling or offering to sell its CoreValve System in the United States. Today's ruling has...

Medtronic CRT Devices Now Approved to Treat Patients with AV Block and Reduced Heart Function

April 10, 2014 7:33 pm | by The Associated Press | News | Comments

Medtronic, Inc. has announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with Medtronic cardiac resynchronization therapy-pacemakers and -defibrillators (CRT-P and CRT-D)...

Advertisement

'IN.PACT Admiral' Drug-Coated Balloon from Medtronic Outperforms Standard Angioplasty

April 7, 2014 10:34 am | by Medtronic Inc. | News | Comments

Patients with peripheral artery disease in the upper leg experienced significantly better outcomes at 12 months after treatment with the IN.PACT Admiral drug-coated balloon from Medtronic, Inc. than with standard balloon angioplasty, according to a landmark...

Study Backs Nonsurgical Way to Fix Heart Valves

March 31, 2014 11:52 am | by Marilynn Marchione, AP Chief Medical Writer | News | Comments

A new study gives a big boost to fixing a bad aortic valve, the heart's main gate, without open-heart surgery. Survival rates were better one year later for people who had a new valve placed through a tube into an artery instead. The results...

Photos of the Day: Repairing the Heart Without Surgery

March 31, 2014 11:51 am | by The Associated Press | News | Comments

A new study gives a big boost to fixing a bad aortic valve, the heart's main gate, without open-heart surgery. Survival rates were better one year later for people who had a new valve placed through a tube into an artery instead...   

Medtronic CoreValve® System Demonstrates Long-Term Durability

March 31, 2014 8:22 am | by The Associated Press | News | Comments

Medtronic, Inc. has announced the final follow-up results from the CoreValve® CE Pivotal Study, which demonstrated excellent long-term durability at four years in patients with severe aortic stenosis who were treated with the self-expanding...

World's First Transcatheter Valve, Medtronic Melody® Transcatheter Pulmonary Valve Shows Positive Clinical Outcomes in Real-World Study

March 30, 2014 11:30 am | by The Associated Press | News | Comments

Medtronic, Inc. has announced the one-year results of the Melody® Transcatheter Pulmonary Valve (TPV) U.S. Post-Approval Study, which found that real-world use of the Melody TPV was associated with high procedural success, excellent valve...

Medtronic CoreValve System Results Superior to Open-Heart Surgery at One Year in U.S. Pivotal Trial

March 29, 2014 8:22 am | by The Associated Press | News | Comments

Medtronic, Inc. has announced that the CoreValve System showed results superior to surgical aortic valve replacement (SAVR) at one year in the High Risk Study of its CoreValve U.S. Pivotal Trial, which evaluated patients with severe aortic...

Deep Brain Stimulation Devices Market for Parkinson's disease Expected to Reach USD 9.4 Billion Globally in 2019

March 18, 2014 7:28 am | by PR Newswire | News | Comments

According to a new market report published by Transparency Market Research "Deep Brain Stimulation Devices Market for Parkinson's Disease (North America, Europe, Asia-Pacific and Latin America)- Global Industry Analysis, Size, Share, Growth...

Medtronic Wins European Patent Office Ruling

March 6, 2014 2:23 pm | by Medtronic | News | Comments

Medtronic, Inc. has announced that the European Patent Office has invalidated, in its entirety, the Edwards Lifesciences EP2055266 Spenser patent which was the basis for the Aug. 26, 2013  injunction prohibiting sales of the CoreValve System...

DMC Cardiovascular Institute Announces First Use of Miniature Cardiac Monitor

February 26, 2014 2:34 pm | by PR Newswire | News | Comments

The Detroit Medical Center (DMC) announced that it is one of the first hospitals in the world to implant the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System in a patient, the smallest implantable cardiac monitoring device... 

First U.S. Implant of World's Smallest, Minimally Invasive Cardiac Pacemaker

February 20, 2014 9:17 am | by The Associated Press | News | Comments

Continuing its leadership in advanced pacing technology and device miniaturization, Medtronic, Inc. (NYSE: MDT), today announced the first U.S. implant of the world's smallest pacemaker: the Micra(TM) Transcatheter Pacing System (TPS). The...

Global Launch of Medtronic’s Miniature Cardiac Monitor

February 19, 2014 9:39 am | by Medtronic | News | Comments

Medtronic, Inc. has announced U.S. Food and Drug Administration 510(k) clearance, CE Mark, and the global launch of its Reveal LINQ Insertable Cardiac Monitor System, the smallest implantable cardiac monitoring device available for patients...

Study: Insertable Cardiac Monitors Detect Atrial Fibrillation in Stroke Patients Better than Standard Care

February 18, 2014 10:47 am | by Medtronic | News | Comments

Medtronic, Inc. has announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) Clinical Trial, which found that continuous cardiac monitoring with the Reveal XT Insertable Cardiac Monitor (ICM) was superior...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading